Injection device
Latest NOVARTIS AG Patents:
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
- Polyomavirus neutralizing antibodies
- Synthesis of prostate specific membrane antigen (PSMA) ligands
- Cell secreted minibodies and uses thereof
- Combination therapy using a chimeric antigen receptor
Description
Claims
The ornamental design for an injection device, as shown.
Referenced Cited
U.S. Patent Documents
| 7651512 | January 26, 2010 | Chelak |
| 7896843 | March 1, 2011 | Kriesel |
| D830539 | October 9, 2018 | Boyaval |
| D841155 | February 19, 2019 | McMenamin |
| D841156 | February 19, 2019 | McMenamin |
| D862690 | October 8, 2019 | Jansen |
| D869647 | December 10, 2019 | Dorsey |
| D888942 | June 30, 2020 | Cannamela |
| D897184 | September 29, 2020 | Perkins, Jr. |
| D897185 | September 29, 2020 | Perkins, Jr. |
| D903856 | December 1, 2020 | Nicholas |
| D910836 | February 16, 2021 | Sandberg |
| D910837 | February 16, 2021 | Ono |
Patent History
Patent number: D928939
Type: Grant
Filed: Dec 12, 2019
Date of Patent: Aug 24, 2021
Assignee: NOVARTIS AG (Basel)
Inventors: Neil Cammish (Manchester), John Palmer-Felgate (Horsham), Mark Horlock (Warrington), Congyi Huang (Klagenfurt), Adrian Von Muralt (Basel)
Primary Examiner: David G Muller
Application Number: 29/716,797
Type: Grant
Filed: Dec 12, 2019
Date of Patent: Aug 24, 2021
Assignee: NOVARTIS AG (Basel)
Inventors: Neil Cammish (Manchester), John Palmer-Felgate (Horsham), Mark Horlock (Warrington), Congyi Huang (Klagenfurt), Adrian Von Muralt (Basel)
Primary Examiner: David G Muller
Application Number: 29/716,797
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)